Bombardier and AnorMed in the news:
The plane and train manufacturer reported a slow quarter in its regional jets with only 26 planes delivered this quarter as compared to 39 last year. The aerospace division has seen margins decline due to competition mainly from Brazilian plane manufacturer Embraer SA. The market for regional jets has not recovered from the 9/11 attacks and Bombardier is now only producing 7 or 8 planes a month. Bombardier has been able to grow the business jet segment but will encounter more competition in this area from Embraer as well.
The company has not been able to reduce costs fast enough to off set the decline in orders and until it does is not likely to see earnings improve. There is no reason to own this company and there won’t be until the regional jet market picks up and Bombardier is able to manage costs more effectively.
Canadian biotech firm AnorMed Inc (AOM-T) is trying to fend off an unwanted takeover attempt by Genzyme Corp (GENZ-Q). The proposed $350 million offer would see AnorMed shareholders receive $8.55 per share. The news has pushed AnorMed shares up by almost 100% today as the shares closed at $10.99 up $5.44.
AnorMed is currently in stage III clinical trials with Mozobil a drug developed for cancer patients undergoing stem cell transplants. The company is also in the late stages of development of a promising HIV drug.
AnorMed management does not believe the current offer fully reflects potential shareholder value of the company which they believe should be valued in the $12 - $13 range. AnorMed management is not opposed to a takeover just not at this price.
AOM may be an interesting speculation now that it is in play, there is an opportunity to participate in a potential take over bidding war with limited down side risk.
The second quarter US GDP came in at 2.9%, slightly lower than most had expected indicating that the US economy is not as strong as first believed. This information should confirm to the Federal Reserve that their decision to hold interest rates was correct. If the payroll numbers on Friday are lower than forecast coming in any less than 100,000 and investors should expect the Fed to remain on hold and we may see a change in bias as well.
Stats Canada reported that Canadian merchandise trade surplus declined by $4 billion to $4.2 billion in the second quarter. The decline was mainly attributed to a decline in the exports of goods while imports remain strong.
The strength in the Canadian dollar has made imported goods much more attractive but has at the same time made it much more difficult for exporters to compete in the global market.
The Bank of Canada will have to be very cautious regarding any change in interest rates which would make the Canadian dollar more attractive to foreign investors creating the possibility of the trade surplus becoming a trade deficit.
For more information go to www.campbellreport.com
